Featured
    2 days ago

    CEO Spotlight: Acurx Pharmaceuticals CEO Is Confident His Ibezapolstat Can Earn Front-Line Designation To Treat C. difficile ($ACXP)

    Acurx Pharmaceuticals’ (NASDAQ: ACXP) mission in bringing to market an effective and durable treatment for…
    Featured
    4 weeks ago

    KwikClick, Inc. Is Disrupting The E-commerce Ecosystem ($KWIK)

    Total annual retail e-commerce sales in the US are slated to surpass the $1 trillion…
    Featured
    November 30, 2022

    First Wave BioPharma Stock In Play After Filing IND To Accelerate Bringing Enhanced Adrulipase To Market ($FWBI)

    First Wave BioPharma (NASDAQ: FWBI) reached a milestone that could quickly become a catalyst. And…
    Featured
    October 31, 2022

    Yes, KWIK Really Does Have A Game-Changing Platform Accretive To The Trillion Dollar E-Commerce Landscape…Here’s Proof ($KWIK)

    Most investors have heard the term “game changer” when describing a company offering innovative products…
    Featured
    October 26, 2022

    FatBrain AI Keeps Getting Bigger, Creating A Value Proposition Too Big To Ignore ($LZGI)

    FatBrain AI (OTCQB: LZGI) is getting bigger. And it’s happening fast. Following a recent announcement…
    Featured
    October 18, 2022

    Kaival Brands’ Stock Is Soaring 60% In October As BIDI®Stick Phamacokinetics Supports U.S. Marketing Approvals ($KAVL)

    Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) stock is higher by over 60% since the…
      Featured
      2 days ago

      CEO Spotlight: Acurx Pharmaceuticals CEO Is Confident His Ibezapolstat Can Earn Front-Line Designation To Treat C. difficile ($ACXP)

      Acurx Pharmaceuticals’ (NASDAQ: ACXP) mission in bringing to market an effective and durable treatment for C. difficile was provided a…
      Featured
      4 weeks ago

      KwikClick, Inc. Is Disrupting The E-commerce Ecosystem ($KWIK)

      Total annual retail e-commerce sales in the US are slated to surpass the $1 trillion mark for the first time,…
      Featured
      November 30, 2022

      First Wave BioPharma Stock In Play After Filing IND To Accelerate Bringing Enhanced Adrulipase To Market ($FWBI)

      First Wave BioPharma (NASDAQ: FWBI) reached a milestone that could quickly become a catalyst. And if that’s the case, current…
      Featured
      October 31, 2022

      Yes, KWIK Really Does Have A Game-Changing Platform Accretive To The Trillion Dollar E-Commerce Landscape…Here’s Proof ($KWIK)

      Most investors have heard the term “game changer” when describing a company offering innovative products or services. But, truth be…
      Back to top button